CGI and Körber announce global partnership to enable pharmaceutical and life sciences clients to improve production operations
- None.
- None.
Insights
The strategic partnership between CGI and Körber marks a significant development in the pharmaceutical and life sciences sectors. The integration of Körber's Werum PAS-X MES Suite with CGI's services promises to enhance production processes for pharma companies. This collaboration is expected to yield improvements in efficiency, accuracy and safety, which are critical factors in the highly regulated pharmaceutical industry.
From a market perspective, this partnership could position CGI more favorably within the competitive landscape of IT consulting, potentially leading to an increase in market share and revenue growth. The emphasis on real-time data and Industry 5.0 insights aligns with the broader industry trend towards digital transformation and operational excellence. As CGI already provides solutions to a substantial portion of the top global biotech and pharmaceutical companies, this partnership may enhance CGI's existing client relationships and attract new clients looking for advanced MES solutions.
The use of PAS-X MES by Körber, which is compliant with Good Manufacturing Practices (GMP), is a critical component in the pharmaceutical manufacturing process. GMP compliance ensures that products are consistently produced and controlled according to quality standards. The system's ability to present a comprehensive view of data from diverse integrated systems can expedite decision-making processes, which is essential in an industry where product development timelines are crucial.
For pharmaceutical companies, the shorter time-to-market and reduced production costs promised by this partnership could lead to a competitive advantage. This is particularly relevant as the industry faces pressure to deliver innovative treatments quickly amidst rising research and development costs. Additionally, the patient-centric approach facilitated by the MES could contribute to improved patient outcomes, aligning with the industry's move towards more personalized medicine.
The integration of robust IT and operational technology (OT) security as part of the partnership is a critical aspect for the pharmaceutical industry, which is increasingly targeted by cyber threats. The secure implementation of MES services is paramount to protect sensitive data and intellectual property. CGI's expertise in business consulting and MES services, coupled with a focus on security, can mitigate the risks associated with digital transformation.
Furthermore, the operational integration that CGI provides ensures that the transition to the new system is not only technologically sound but also secure from a data protection standpoint. This integrated approach to cybersecurity can be a differentiating factor for CGI in the market, as clients prioritize data security in their digital operations.
Stock Market Symbols
GIB (NYSE)
GIB.A (TSX)
www.cgi.com/newsroom
"CGI works side-by-side with clients to transform data into actionable insights to drive smart, sustainable and resilient operations," said Tim Hurlebaus President,
Körber's platform serves as a digital, real-time process controller to shorten time-to-market, lower production costs and enable a more patient-centric approach, improving outcomes and leading to improved health. Compliant with Good Manufacturing Practices, PAS-X MES presents a comprehensive view of data from diverse integrated systems, enabling faster and more informed decisions, which can be a critical advantage in an industry where timing and accuracy are paramount.
"Our PAS-X Products and Service Suites facilitate seamless digital transformation projects at our customers globally. By combining forces with CGI's global presence, expertise and complementary service portfolio in pharma and life sciences, we can offer a unique and compelling value proposition. CGI is one of the key partners to continue to expand our offering to our global customers" says Jan-Henrik Dieckert, COO Software, Körber Business Area Pharma.
Embedding robust IT and operational technology (OT) security, CGI's business consulting and MES services expertise enables faster, more seamless, and operationally integrated implementation of the platform, including transformation through technical integration, data migration, and organizational change management and adoption.
"In our global client insights research, pharma and life sciences executives said optimizing operations is their top business priority. CGI serves as a trusted advisor to help them achieve this priority through ROI-led digitization investments," said Maiken Lykke, Senior Vice-President, CGI Denmark. "We work collaboratively with clients to build solutions that tailor the right mix of services and technologies for their needs. We are pleased to partner with Körber to address the unique client challenges in this industry."
CGI delivers clinical and IT solutions for 11 of the top 20 global biotech and pharmaceutical companies, including helping these organizations optimize their processes; launch new therapies for cancer and rare diseases; and drive digital transformation across their research & development, manufacturing and commercial functions globally.
Founded in 1976, CGI is among the largest independent IT and business consulting services firms in the world. With 91,500 consultants and professionals across the globe, CGI delivers an end-to-end portfolio of capabilities, from strategic IT and business consulting to systems integration, managed IT and business process services and intellectual property solutions. CGI works with clients through a local relationship model complemented by a global delivery network that helps clients digitally transform their organizations and accelerate results. CGI Fiscal 2023 reported revenue is
We are Körber – an international technology group with more than 12,000 employees at over 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape the technological change. In the Business Areas Digital, Pharma, Supply Chain, and Technologies, we offer products, solutions and services that inspire. We act fast to customer needs, we execute ideas seamlessly, and with our innovations we create added value for our customers. In doing so, we are increasingly building on ecosystems that solve the challenges of today and tomorrow. Körber AG is the holding company of the Körber Group.
At the Körber Business Area Pharma we are delivering the difference along the pharma value chain with our unique portfolio of integrated solutions. With our software solutions we help drug manufacturers to digitize their pharmaceutical, biotech and cell & gene therapy production. The Werum PAS-X MES Suite is recognized as the world's leading Manufacturing Execution System for pharma, biotech and cell & gene. Our Werum PAS-X Savvy Suite accelerates product commercialization with data analytics and AI solutions and uncovers hidden business value. Learn more at www.koerber-pharma.com.
View original content:https://www.prnewswire.com/news-releases/cgi-and-korber-announce-global-partnership-to-enable-pharmaceutical-and-life-sciences-clients-to-improve-production-operations-302039977.html
SOURCE CGI Inc.
FAQ
What is the partnership between CGI and Körber about?
What are the benefits of the partnership?
How will the partnership impact CGI's clients?
What is Körber's PAS-X MES?
What is CGI's role in the partnership?
